David C. Wheeler
3 ta ish
University College London
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter +11
Maqola20205 iqtibosABIGlobal kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Adeera Levin, Marcello Tonelli, Joseph V. Bonventre +66
Sharh maqola20172 iqtibosABICanagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal +21
Maqola20192 iqtibosABI